Advanced search
1 file | 553.94 KB Add to list

Ceftriaxone-induced immune hemolytic anemia as a life-threatening complication of antibiotic treatment of 'chronic Lyme disease'

MAARTEN DE WILDE (UGent) , Marijn Speeckaert (UGent) , Rutger Callens (UGent) and Wim Van Biesen (UGent)
(2017) ACTA CLINICA BELGICA. 72(2). p.133-137
Author
Organization
Abstract
Chronic Lyme disease' is a controversial condition. As any hard evidence is lacking that unresolved systemic symptoms, following an appropriately diagnosed and treated Lyme disease, are related to a chronic infection with the tick-borne spirochaetes of the Borrelia genus, the term 'chronic Lyme disease' should be avoided and replaced by the term 'post-treatment Lyme disease syndrome.' The improper prescription of prolonged antibiotic treatments for these patients can have an impact on the community antimicrobial resistance and on the consumption of health care resources. Moreover, these treatments can be accompanied by severe complications. In this case report, we describe a life-threatening ceftriaxone-induced immune hemolytic anemia with an acute kidney injury (RIFLE-stadium F) due to a pigment-induced nephropathy in a 76-year-old woman, who was diagnosed with a so-called 'chronic Lyme disease.'
Keywords
ANTIBODIES, THERAPY, CEPHALOSPORINS, SEROLOGY, TRIAL, DEATH, 'Chronic Lyme disease', Ceftriaxone, Drug-induced hemolytic anemia

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 553.94 KB

Citation

Please use this url to cite or link to this publication:

MLA
DE WILDE, MAARTEN et al. “Ceftriaxone-induced Immune Hemolytic Anemia as a Life-threatening Complication of Antibiotic Treatment of ‘Chronic Lyme Disease’.” ACTA CLINICA BELGICA 72.2 (2017): 133–137. Print.
APA
DE WILDE, M., Speeckaert, M., Callens, R., & Van Biesen, W. (2017). Ceftriaxone-induced immune hemolytic anemia as a life-threatening complication of antibiotic treatment of “chronic Lyme disease.” ACTA CLINICA BELGICA, 72(2), 133–137.
Chicago author-date
DE WILDE, MAARTEN, Marijn Speeckaert, Rutger Callens, and Wim Van Biesen. 2017. “Ceftriaxone-induced Immune Hemolytic Anemia as a Life-threatening Complication of Antibiotic Treatment of ‘Chronic Lyme Disease’.” Acta Clinica Belgica 72 (2): 133–137.
Chicago author-date (all authors)
DE WILDE, MAARTEN, Marijn Speeckaert, Rutger Callens, and Wim Van Biesen. 2017. “Ceftriaxone-induced Immune Hemolytic Anemia as a Life-threatening Complication of Antibiotic Treatment of ‘Chronic Lyme Disease’.” Acta Clinica Belgica 72 (2): 133–137.
Vancouver
1.
DE WILDE M, Speeckaert M, Callens R, Van Biesen W. Ceftriaxone-induced immune hemolytic anemia as a life-threatening complication of antibiotic treatment of “chronic Lyme disease.”ACTA CLINICA BELGICA. 2017;72(2):133–7.
IEEE
[1]
M. DE WILDE, M. Speeckaert, R. Callens, and W. Van Biesen, “Ceftriaxone-induced immune hemolytic anemia as a life-threatening complication of antibiotic treatment of ‘chronic Lyme disease,’” ACTA CLINICA BELGICA, vol. 72, no. 2, pp. 133–137, 2017.
@article{8519616,
  abstract     = {Chronic Lyme disease' is a controversial condition. As any hard evidence is lacking that unresolved systemic symptoms, following an appropriately diagnosed and treated Lyme disease, are related to a chronic infection with the tick-borne spirochaetes of the Borrelia genus, the term 'chronic Lyme disease' should be avoided and replaced by the term 'post-treatment Lyme disease syndrome.' The improper prescription of prolonged antibiotic treatments for these patients can have an impact on the community antimicrobial resistance and on the consumption of health care resources. Moreover, these treatments can be accompanied by severe complications. In this case report, we describe a life-threatening ceftriaxone-induced immune hemolytic anemia with an acute kidney injury (RIFLE-stadium F) due to a pigment-induced nephropathy in a 76-year-old woman, who was diagnosed with a so-called 'chronic Lyme disease.'},
  author       = {DE WILDE, MAARTEN and Speeckaert, Marijn and Callens, Rutger and Van Biesen, Wim},
  issn         = {1784-3286},
  journal      = {ACTA CLINICA BELGICA},
  keywords     = {ANTIBODIES,THERAPY,CEPHALOSPORINS,SEROLOGY,TRIAL,DEATH,'Chronic Lyme disease',Ceftriaxone,Drug-induced hemolytic anemia},
  language     = {eng},
  number       = {2},
  pages        = {133--137},
  title        = {Ceftriaxone-induced immune hemolytic anemia as a life-threatening complication of antibiotic treatment of 'chronic Lyme disease'},
  url          = {http://dx.doi.org/10.1080/17843286.2016.1180829},
  volume       = {72},
  year         = {2017},
}

Altmetric
View in Altmetric
Web of Science
Times cited: